China Pharma Holdings
CPHI • AMEX
China Pharma Holdings is a drug manufacturers - specialty & generic company in the healthcare sector trading on AMEX, led by CEO Zhilin Li, with a market cap of $3.2M.
CEOZhilin Li
Market Cap$3.2M
Drug Manufacturers - Specialty & Generic
Healthcare
Employees239.0
Websitechinapharmaholdings.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for China Pharma Holdings
Date
Monday, March 30, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2025
Earnings History
Past 12 earnings reports for China Pharma Holdings
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 12, 2025 | Q3 2025 | -$0.17 | — | $756.2K | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.16 | — | $1.0M | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.24 | — | $1.1M | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.04 | — | $1.1M | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.06 | — | $1.1M | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.09 | — | $924.9K | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.07 | — | $1.4M | — | 10-Q |
| Apr 1, 2024 | Q4 2023 | -$0.73 | — | $2.2M | — | — |
| Nov 13, 2023 | Q3 2023 | -$0.30 | — | $1.8M | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.30 | — | $1.1M | — | 10-Q |
| May 12, 2023 | Q1 2023 | -$0.30 | — | $2.0M | — | 10-Q |
| Mar 30, 2023 | Q4 2022 | -$1.00 | — | $2.9M | — | 10-K |